Pharmaceutical compounds
US11786524B2 · kind B2 · utility
0Cited by
18References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 3, 2021 |
| Grant date | Oct 17, 2023 |
| Priority date | — |
| Expiry date | Jun 6, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to compounds that inhibit or modulate the activity of Chk-1 kinase. Also provided are pharmaceutical compositions containing the compounds and the therapeutic uses of the compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.